Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1986-2-24
pubmed:abstractText
Quinone and hydroquinone forms of rifampin accumulated in normal polymorphonuclear leukocytes (PMN) (maximal cellular to extracellular concentration ratio [C/Emax] +/- standard error of the mean, 9.36 +/- 0.54 and 8.82 +/- 0.65, respectively, after 5 to 10 min) and chronic granulomatous disease PMN (C/Emax, 13.76 +/- 0.77 and 14.29, respectively). Uptake of rifampin was influenced by incubation temperature and extracellular pH but not by phorbol myristate acetate stimulation or metabolic inhibitors. At extracellular concentrations between 0.06 and 5.0 mg/liter, rifampin significantly reduced the number of staphylococci surviving inside chronic granulomatous disease PMN, thus compensating for the bactericidal defect inherent with this disease. Spontaneous migration and chemotaxis of normal PMN were unaffected by rifampin. However, phagocytosis of yeast particles and oxygen consumption of stimulated PMN were moderately depressed, and O2- production and chemiluminescence were significantly depressed in a dose-dependent manner. The bactericidal activity of normal PMN was not impaired. Inhibition of chemiluminescence and O2- release were also observed in a cell-free system. We conclude that rifampin possesses favorable characteristics for the effective elimination of intracellular microorganisms. Further studies are needed to evaluate the in vivo significance of ion scavenging by rifampin, which could be hazardous to immunocompromised patients.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-1052391, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-360374, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-3969311, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-4135569, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-4346473, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-4392562, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-5026288, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-5496991, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-6279585, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-6318656, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-6356278, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-6417331, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-6742818, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-6958028, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-7028436, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-7038325, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-7089503, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-7103442, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-7161229, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-718704, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-7219526, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-7333866, http://linkedlifedata.com/resource/pubmed/commentcorrection/3004324-7416618
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
667-74
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1985
pubmed:articleTitle
Uptake, intracellular activity, and influence of rifampin on normal function of polymorphonuclear leukocytes.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't